UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

The Lancet (British edition), 2015-05, Vol.385 (9982), p.2107-2117

2015

Volltextzugriff (PDF)

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

The Lancet (British edition), 2009-04, Vol.373 (9671), p.1275-1281

2009

Volltextzugriff (PDF)

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

The Lancet (British edition), 2014-02, Vol.383 (9917), p.622-629

2014

Volltextzugriff (PDF)

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9699), p.1423-1431

2009

Volltextzugriff (PDF)

RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials

Cardiovascular drugs and therapy, 2013-04, Vol.27 (2), p.171-179

2013

Volltextzugriff (PDF)

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate

PloS one, 2012-07, Vol.7 (7), p.e41281-e41281

2012

Volltextzugriff (PDF)

A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone

Clinical cardiology (Mahwah, N.J.), 2008-04, Vol.31 (4), p.153-158

2008

Volltextzugriff (PDF)

Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension

Journal of the American College of Cardiology, 2011-09, Vol.58 (11), p.1176-1182

2011

Volltextzugriff (PDF)

Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients

Journal of hypertension, 2014-03, Vol.32 (3), p.525-533

2014

Volltextzugriff (PDF)

Demographics and concomitant disorders in heart failure

The Lancet (British edition), 2003-07, Vol.362 (9378), p.147-158

2003

Volltextzugriff (PDF)

Renal sympathetic nerve ablation for treatment‐resistant hypertension

British journal of clinical pharmacology, 2013-10, Vol.76 (4), p.495-503

2013

Volltextzugriff (PDF)

Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2)

European journal of heart failure, 2016-01, Vol.18 (1), p.38-45

2016

Volltextzugriff (PDF)

Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction

American journal of physiology. Heart and circulatory physiology, 2008-04, Vol.294 (4), p.H1804-H1814

2008

Volltextzugriff (PDF)

Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function

BMC nephrology, 2021-04, Vol.22 (1), p.152-152, Article 152

2021

Volltextzugriff (PDF)

Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure

BioFactors (Oxford), 2003, Vol.18 (1-4), p.91-100

2003

Volltextzugriff (PDF)

Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failure

ESC Heart Failure, 2022-02, Vol.9 (1), p.196-212

2022

Volltextzugriff (PDF)

Age‐related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk

ESC Heart Failure, 2020-06, Vol.7 (3), p.1344-1361

2020

Volltextzugriff (PDF)

Radial artery pulse wave analysis for non-invasive assessment of coronary artery disease

International journal of cardiology, 2013-08, Vol.167 (3), p.917-924

2013

Volltextzugriff (PDF)

3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats

PloS one, 2011-07, Vol.6 (7), p.e22777-e22777

2011

Volltextzugriff (PDF)

The Thrill of Success: Central Arterial-Venous Anastomosis for Hypertension

Current hypertension reports, 2014-12, Vol.16 (12), p.497-497, Article 497

2014

Volltextzugriff (PDF)

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation (New York, N.Y.), 2012-12, Vol.126 (25), p.2976-2982

2012

Volltextzugriff (PDF)

Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System

Circulation (New York, N.Y.), 2011-01, Vol.123 (2), p.209-215

2011

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

ThemaHypertension

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(84)
Reviews
(1)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review

RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate

A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone

Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension

Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients

Sympathetic Response and Outcomes Following Renal Denervation in Patients with Chronic Heart Failure: 12-Month Outcomes From the SYMPLICITY HF Feasibility Study

Demographics and concomitant disorders in heart failure

Renal sympathetic nerve ablation for treatment‐resistant hypertension

Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2)

Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction

Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure

Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failure

Age‐related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk

Radial artery pulse wave analysis for non-invasive assessment of coronary artery disease

3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats

The Thrill of Success: Central Arterial-Venous Anastomosis for Hypertension

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System

Aktive Filter

Suchergebnisse filtern